FCM
CBAY

Farallon Capital Management’s Cymabay Therapeutics CBAY Stock Holding History

Farallon Capital Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-550,000
Closed -$7.15M – 107
2018
Q1 		$7.15M Sell
550,000
-550,000
-50% -$7.15M 0.05% 78
2017
Q4 		$10.1M Buy
+1,100,000
New +$10.1M 0.08% 65